Celemics CRV Panel

Dec 14, 2020

Celemics has launched its CRV Panel, a multiplexed, target enrichment panel for next-generation sequencing-based identification of common human respiratory viruses, including SARS-CoV-2. The research-use-only assay detects a total of 39 strains of nine viruses including coronaviruses, rhinoviruses, influenzas, and respiratory syncytial viruses. The panel is bundled with non-cloud-based bioinformatics software that enables a complete workflow. The product is available in the US, Europe, Latin America, the Middle East, Singapore, Malaysia, and Thailand via Celemics' certified retailers.

Celemics CRV Panel

De Novo Mutation Rate in Humans Higher Than Assumed, Multigenerational Genomics Study Suggests

Watchmaker Genomics, Revvity Partner to Automate Next-Gen Sequencing Workflows

Tempus Signs $200M Deal With AstraZeneca, Pathos AI to Develop Multimodal Cancer Foundation Model

Thermo Fisher Scientific Reports Flat Q1 Revenues, Beating Expectations

ABL Diagnostics to Commercialize Institut Pasteur RNA Seq-Based HPV Test